单位(元)华安国证生物医药ETF发起式联接A(012598)资产负债表 |
报告期 |
2023/12/31 |
2023/8/13 |
2023/6/30 |
2022/12/31 |
资产 |
银行存款 |
11,094,457 |
9,045,178 |
8,114,151 |
4,842,039 |
结算备付金 |
20,442 |
67,579 |
129,237 |
16,092 |
存出保证金 |
33,008 |
15,550 |
20,284 |
7,188 |
交易性金融资产 |
154,089,987 |
111,268,957 |
85,937,257 |
62,048,055 |
其中:股票投资 |
- |
111,268,957 |
85,937,257 |
62,048,055 |
基金投资 |
154,089,987 |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
- |
1,896,722 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
1,731,259 |
9,851,584 |
1,334,798 |
394,041 |
其他资产 |
- |
- |
- |
- |
资产总计 |
166,969,154 |
130,248,847 |
95,535,727 |
69,204,136 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
808,832 |
2,198,585 |
942,310 |
- |
应付赎回款 |
2,661,696 |
3,521,716 |
2,472,590 |
2,320,820 |
应付管理人报酬 |
3,791 |
20,099 |
36,328 |
22,516 |
应付托管费 |
758 |
4,020 |
7,266 |
4,503 |
应付销售服务费 |
20,813 |
7,295 |
13,736 |
8,100 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
1,766 |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
232,457 |
88,767 |
136,992 |
97,042 |
负债合计 |
3,730,113 |
5,840,482 |
3,609,221 |
2,452,981 |
所有者权益 |
实收基金 |
297,687,605 |
220,783,955 |
169,283,154 |
98,068,795 |
未分配利润 |
-134,448,563 |
-96,375,589 |
-77,356,648 |
-31,317,640 |
所有者权益合计 |
163,239,041 |
124,408,366 |
91,926,505 |
66,751,155 |
负债和所有者权益总计 |
166,969,154 |
130,248,847 |
95,535,727 |
69,204,136 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。